BRIEF-Novavax says FDA has granted fast track designation for its RSV F-protein vaccine
May 25, 2016 at 08:52 AM EDT
* Says U.S. FDA has granted fast track designation for its RSV F-protein nanoparticle vaccine candidate Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)